Wake Forest University Health Sciences
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Wake Forest University Health Sciences sits in the top decile of US sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count).
Wake Forest University Health Sciences: 1,140 sponsored US clinical trials, 174 recruiting.
Wake Forest University Health Sciences sponsors 1,140 registered US clinical trials on ClinicalTrials.gov, 174 of them currently recruiting, and 724 completed. 111 of these trials are in Phase 3-4 (later-stage) and 239 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 9 trials.
Top-decile sponsor footprint
Wake Forest University Health Sciences ranks in the top decile of sponsors by registered trial count (#27 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
724 of 885 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,140 total, page 4 of 23
Experimental Round Spermatid Injection (ROSI) to Treat Infertile Couples
NCT04298255
Effects of Systematic Cervical Exam Training on Labor and Delivery Care
NCT04421768
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
NCT04253964
Cetuximab After Immunotherapy for the Treatment of Head and Neck Squamous Cell Cancer
NCT04375384
Prospective Measurement of Normal Venous Sinus Pressures
NCT03948971
Pelvic and Acetabular Fracture: A Prospective Observational Study
NCT04615104
Self Reported Pain in Women While Undergoing Treatment for Non-metastatic Breast Cancer
NCT04174742
Muscle Fiber Fragments for Improved Function of Rotator Cuff Musculature Following Rotator Cuff Repair
NCT03752034
Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
NCT03998202
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity
NCT03890614
Cereset Research Exploratory Study
NCT03777267
APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO)
NCT03615235
Randomized Controlled Trial for Treatment of Pain and Assessment of Wound Healing in Chronic Venous Leg Ulcers Using Near Infrared Laser Therapy
NCT03716167
Brain Energy for Amyloid Transformation in Alzheimer's Disease Study
NCT03472664
Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy
NCT03555851
Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo
NCT04096170
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
NCT04207931
Reliability of Pupil Response to Acute Pain
NCT02628314
Use of an Integrated Orthotic and Rehabilitation Initiative for Treatment of Lower Extremity Musculoskeletal Disorders
NCT05780502
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
NCT02422641
Wake Forest Alzheimer's Disease Clinical Core
NCT03140865
Facial Analysis to Classify Difficult Intubation
NCT01612949
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
NCT00900471
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
NCT01890486
GLP-1s to Enhance Lasting Optimal Weight
NCT06861439
Assessing Chest Pain Using Point-of-Care High-Sensitivity Troponin I in the Emergency Department
NCT06899776
Telehealth-Enhanced Assessment and Management
NCT06247254
A Web-based Program to Help Caregivers of Lung Patients Learn About Available Supportive Care Resources
NCT06383988
Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors
NCT06340503
Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)
NCT05416333
Calcium Carbonate on Labor Induction
NCT06352775
Developing an Internet-Delivered Sexual Health Program for Breast Cancer Survivors, SHINE Trial
NCT06216574
The Bennett Kids PowerUP Project
NCT05858580
Experience With Topical Acne Treatment
NCT05582434
Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream
NCT05723601
Phase II Trial of Trilaciclib, Pembrolizumab, Gemcitabine and Carboplatin in Metastatic Triple-Negative Breast Cancer
NCT06027268
Deucravacitinib Adherence Study
NCT05570955
Barbed-suture Efficiency Study for Sacrocolpopexy
NCT05760794
Contingency Management for Drug Use: Does Age Matter?
NCT05521854
Effects of Dance and Music Appreciation on Brain Health and Fitness in People at Risk for Alzheimer's Disease
NCT05507905
Immune Signature Analysis of Disease Progression in Post Immunotherapy Lung Cancer Patients
NCT05415358
Prospective Evaluation of Intrathecal Targeted Drug Delivery for Cancer Associated Pain
NCT05674240
The Arteriovenous Vascular (AV) ACCESS Trial
NCT04646226
Long-term Effectiveness of the Antiobesity Medication Phentermine
NCT05176626
Primary Care Implementation and Evaluation of Coach McLungs
NCT05059210
Metformin for Older Patients With Heart Failure With Preserved Ejection Fraction
NCT05093959
Implementation and Effectiveness Trial of HN-STAR
NCT04208490
Enhancing Rural Health Via Cardiovascular Telehealth for Rural Patients Implementation (E-VICTORS)
NCT04617834
Xerosis and Use of Topical Moisturizer
NCT04341623
FNS (FEMORAL NECK SYSTEM) Study
NCT04577261
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 96 |
| Phase 2 | 143 |
| Phase 3 | 31 |
| Phase 4 | 80 |
Therapeutic Areas
What is open in the Wake Forest University Health Sciences pipeline
174 recruiting of 1,140 indexed (15% open); 724 completed (64%).
Phase mix: 111 late (III/IV) vs 239 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (9 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Wake Forest University Health Sciences: open-pipeline peers nationwide
Peers matched on 1,140 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
Wake Forest University Health Sciences sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,140 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- University of Florida · 1,106 trials · 15% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Baylor University · 15% recruiting · 33 trials
- Cornell University · 15% recruiting · 66 trials
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
Related
What to do with this Wake Forest University Health Sciences page
1,140 registered trials is a research-attention snapshot, not an endorsement of Wake Forest University Health Sciences or any single study.
- 174 of Wake Forest University Health Sciences's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Wake Forest University Health Sciences studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Wake Forest University Health Sciences pipeline card: 1,140 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.